Walgreens Boots Alliance (NYSE: WBA) entered the new fiscal after a disappointing show last year, in terms of shareholder return and financial
Walgreens Boots Alliance (WBA) to report Q1 earnings: What’s in the offing?
Categories
Health Care
Will Rite Aid (RAD) stock soar in 2020 from its yearly high?
Rite Aid Corporation (NYSE: RAD) stock soared to a yearly high of $20.38 on Friday as investors were positive about the company's
Rite Aid (NYSE: RAD) stock soars to 9-month after solid results
Rite Aid Corporation (NYSE: RAD) stock rebounded after better-than-expected earnings results for the third quarter of 2020. The shares soared to a
Avid Bioservices (NASDAQ: CDMO): Q2 2020 Earnings Snapshot
-- Avid Bioservices (NASDAQ: CDMO) reported a second-quarter 2020 loss of $0.03 per share versus a loss of $0.05 per share expected.
Where does Merck (MRK) stand in the cancer-drug race?
Shares of Merck and Co. (NYSE: MRK) this week pared some of their recent gains even as the ex-dividend date approaches. While
Rite Aid (NYSE: RAD) stock remains on cautious stance
Rite Aid Corporation (NYSE: RAD) stock remained on the green territory on Friday after falling over 24% in the past month. The
Veeva Systems (NYSE: VEEV): Q3 2020 Earnings Snapshot
-- Veeva Systems Inc. (NYSE: VEEV) reported its third-quarter 2020 adjusted earnings of $0.60 per share versus $0.54 per share expected. --
Agilent Technologies (NYSE: A): Q4 2019 Earnings Snapshot
-- Agilent Technologies (NYSE: A) reported its fourth-quarter 2019 adjusted earnings of $0.89 per share versus $0.85 per share expected. -- Revenue
Arrowhead Pharmaceuticals (ARWR): FY 2019 Earnings Snapshot
-- Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported earnings of 69 cents per share during fiscal year 2019, compared to a loss of
Affimed (AFMD): Q3 2019 Earnings Snapshot
-- Affimed NV (NASDAQ: AFMD) reported Q3 2019 loss of EUR0.17 per share, vs. EUR0.19 reported last year. -- Revenues were EUR2.1
Medtronic (MDT) Q2 results exceed expectations; lifts FY20 EPS outlook
Medtronic plc (NYSE: MDT) reported stronger-than-expected earnings and revenues for the second quarter of 2020. The management also revised up its full-year
What to expect when Medtronic reports Q2 2020 earnings results?
Medtronic plc (NYSE: MDT) is scheduled to report second quarter 2020 earnings results on Tuesday, November 19, before the market opens. The
Where is Amarin (AMRN) headed after FDA panel favors Vascepa’s label expansion?
Biotech firm Amarin Corporation (NASDAQ: AMRN) had a positive start to the week, with the shares making sharp gains and hitting the
ReWalk Robotics (RWLK) stock plunges to a record low
ReWalk Robotics Ltd. (NASDAQ: RWLK) stock plunged to a record low of $1.94 on Friday as the medical devices company has been
Bio-Path Holdings, Inc. (NASDAQ: BPTH): Q3 2019 Earnings Snapshot
-- Bio-Path Holdings, Inc. (NASDAQ: BPTH) reported a net loss of $2.2 million or $0.78 share for the third quarter of 2019,
CorMedix, Inc. (NYSE: CRMD): Q3 2019 Earnings Snapshot
-- CorMedix, Inc. (NYSE: CRMD) reported a net loss attributable to common shareholders of $32.4 million or $1.35 per share for the
Aurinia Pharmaceuticals (NASDAQ: AUPH): Q3 2019 Earnings Snapshot
-- Aurinia Pharmaceuticals (NASDAQ: AUPH) reported a third-quarter 2019 loss of $0.21 per share versus a loss of $0.15 per share expected.
Titan Pharmaceuticals (TTNP): Q3 2019 Earnings Snapshot
-- Titan Pharmaceuticals (NASDAQ: TTNP) reported Q3 2019 loss of $0.18 per share, vs. $0.21 expected. -- Revenues fell 47% to approx.
Catalyst Pharmaceutical (CPRX): Q3 2019 Earnings Snapshot
-- Catalyst Pharmaceutical (NASDAQ: CPRX) reported third quarter 2019 earnings of $0.13 per share, vs. $0.11 per share expected. -- Net product
BioLineRx (BLRX): Q3 2019 Earnings Snapshot
-- BiolineRX (NASDAQ: BLRX) reported third quarter 2019 operating loss of $6.6 million vs. $6.2 million loss in the year-over period. --
Amicus Therapeutics (FOLD): Q3 2019 Earnings Snapshot
-- Amicus Therapeutics (NASDAQ: FOLD) reported Q3 2019 loss of $0.24 per share, vs. a loss of $0.32 expected. -- Revenues grew